# Longevity Acquisition Corporation (LOAC) Source: https://www.quantisnow.com/company/LOAC Generated: 2026-11-10T06:42:52.883Z - Ticker: LOAC - Exchange: NASDAQ - Sector: Finance - Industry: Business Services - IPO year: 2018 ## Latest LOAC news and filings - 2021-04-07 04:15 UTC [SEC Form EFFECT filed by Longevity Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-effect-filed-by-longevity-acquisition-corporation-594039) - 2021-04-01 17:05 UTC [SEC Form 15-15D filed by Longevity Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-15-15d-filed-by-longevity-acquisition-corporation-577848) - 2021-03-31 17:21 UTC [SEC Form POS AM filed by Longevity Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-longevity-acquisition-corporation-572481) - 2021-03-22 11:42 UTC [SEC Form 25-NSE filed by Longevity Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-longevity-acquisition-corporation-534373) - 2021-03-22 07:00 UTC [4D pharma Announces Completion of Merger With Longevity Acquisition Corporation](https://www.quantisnow.com/insight/4d-pharma-announces-completion-of-merger-with-longevity-acquisition-corporation-533562) - 2021-03-18 18:07 UTC [SEC Form 425] [SEC Form 425 filed by Longevity Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-longevity-acquisition-corporation-527812) - 2021-03-18 12:32 UTC [SEC Form 8-K] [SEC Form 8-K filed by Longevity Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-longevity-acquisition-corporation-526145) - 2021-03-18 12:30 UTC [SEC Form 425] [SEC Form 425 filed by Longevity Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-longevity-acquisition-corporation-526102) - 2021-03-18 12:00 UTC [Longevity Acquisition Corporation Announces Results of Special Meeting of Shareholders](https://www.quantisnow.com/insight/longevity-acquisition-corporation-announces-results-of-special-meeting-of-shareholders-525888) - 2021-03-17 20:42 UTC [SEC Form 425] [SEC Form 425 filed by Longevity Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-longevity-acquisition-corporation-523189) - 2021-03-17 12:59 UTC [SEC Form 425] [SEC Form 425 filed by Longevity Acquisition Corporation](https://www.quantisnow.com/insight/sec-form-425-filed-by-longevity-acquisition-corporation-521029) - 2021-03-03 12:00 UTC [Conference Announcement] [4D Pharma to Present at Upcoming Investor Conferences in March](https://www.quantisnow.com/insight/4d-pharma-to-present-at-upcoming-investor-conferences-in-march-464120) - 2021-03-01 12:00 UTC [Leadership Update] [4D Pharma Appoints John Beck as Chief Financial Officer and Member of the Management Team](https://www.quantisnow.com/insight/4d-pharma-appoints-john-beck-as-chief-financial-officer-and-449824) - 2021-03-01 11:04 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-449676) - 2021-03-01 11:03 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-449622) - 2021-02-26 11:06 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-444201) - 2021-02-26 11:07 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-444200) - 2021-02-26 07:00 UTC [4D Pharma Announces U.S. SEC Declares Registration Statement Effective with Respect to the Issuance of 4D Pharma American Depositary Shares on NASDAQ](https://www.quantisnow.com/insight/4d-pharma-announces-us-sec-declares-registration-statement-effective-with-443793) - 2021-02-25 02:02 UTC [SEC Form PRER14A filed](https://www.quantisnow.com/insight/sec-form-prer14a-filed-431175) - 2021-02-19 22:21 UTC [SEC Form PRER14A filed](https://www.quantisnow.com/insight/sec-form-prer14a-filed-415819) - 2021-02-16 20:16 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-401015) - 2021-02-16 12:36 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-396465) - 2021-02-12 21:21 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-391312) - 2021-02-10 13:40 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-373817) - 2021-02-08 13:00 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-361464) - 2021-02-08 13:00 UTC [Longevity Acquisition Corporation Announces 4D pharma Clinical Trial Collaboration and Supply Agreement for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma](https://www.quantisnow.com/insight/longevity-acquisition-corporation-announces-4d-pharma-clinical-trial-collaboration-and-361434) - 2021-02-08 12:41 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-361287) - 2021-02-08 12:00 UTC [4D pharma Announces Clinical Trial Collaboration and Supply Agreement with Merck KGaA, Darmstadt, Germany and Pfizer to Evaluate MRx0518 in Combination with BAVENCIO® for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma](https://www.quantisnow.com/insight/4d-pharma-announces-clinical-trial-collaboration-and-supply-agreement-with-360980) - 2021-02-03 14:00 UTC [Longevity Acquisition Corporation Announces 4D pharma Update on Oncology Program](https://www.quantisnow.com/insight/longevity-acquisition-corporation-announces-4d-pharma-update-on-oncology-program-346616) - 2021-02-03 13:03 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-346059) - 2021-02-03 12:00 UTC [4D Pharma Presents Update on Oncology Program](https://www.quantisnow.com/insight/4d-pharma-presents-update-on-oncology-program-345451) - 2021-02-03 11:05 UTC [SEC Form 425 filed](https://www.quantisnow.com/insight/sec-form-425-filed-345230) - 2021-01-28 13:31 UTC [SEC Form PRER14A filed](https://www.quantisnow.com/insight/sec-form-prer14a-filed-324246) - 2021-01-08 22:16 UTC [SEC Form PRER14A filed](https://www.quantisnow.com/insight/sec-form-prer14a-filed-270164) - 2020-12-21 13:00 UTC [SEC Form 4 filed](https://www.quantisnow.com/insight/sec-form-4-filed-228776) - 2020-12-21 13:00 UTC [Longevity Acquisition Corporation Announces 4D pharma Joining Landmark Parkinson's Progression Markers Initiative](https://www.quantisnow.com/insight/longevity-acquisition-corporation-announces-4d-pharma-joining-landmark-parkinsons-progression-228752) - 2020-12-21 11:05 UTC [SEC Form 4 filed](https://www.quantisnow.com/insight/sec-form-4-filed-228322) - 2020-12-11 13:00 UTC [Longevity Acquisition Corporation Regains Compliance with Nasdaq Listing Requirement](https://www.quantisnow.com/insight/longevity-acquisition-corporation-regains-compliance-with-nasdaq-listing-requirement-211681) - 2020-11-27 13:00 UTC [4D pharma plc Files SEC Forms in Process to Gain NASDAQ Listing Following Merger with Longevity, a Special Purpose Acquisition Company (SPAC)](https://www.quantisnow.com/insight/4d-pharma-plc-files-sec-forms-in-process-to-gain-184642) - 2020-11-20 19:00 UTC [Longevity Acquisition Corporation Announces Extension of Deadline to Complete a Business Combination](https://www.quantisnow.com/insight/longevity-acquisition-corporation-announces-extension-of-deadline-to-complete-a-173001) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/LOAC - Earnings history: https://www.quantisnow.com/earnings/LOAC - Dividend history: https://www.quantisnow.com/dividends/LOAC - Insider transactions: https://www.quantisnow.com/insiders/LOAC - Options chain: https://www.quantisnow.com/options/LOAC - SEC 8-K filings only: https://www.quantisnow.com/company/LOAC/8-k - RSS and alerts for LOAC: https://www.quantisnow.com/docs/rss-feeds.md